Search Results - "DUPON, M"

Refine Results
  1. 1
  2. 2
  3. 3

    Primary liver abscess due to CC23-K1 virulent clone of Klebsiella pneumoniae in France by Merlet, A., Cazanave, C., Dutronc, H., de Barbeyrac, B., Brisse, S., Dupon, M.

    Published in Clinical microbiology and infection (01-09-2012)
    “…Since the mid-1980s, Klebsiella pneumoniae hypermucoviscous isolates have emerged in Taiwan and other Asian countries. We reported the first autochthonous…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prevalence and factors associated with renal impairment in HIV‐infected patients, ANRS C03 Aquitaine Cohort, France by Déti, EK, Thiébaut, R, Bonnet, F, Lawson‐Ayayi, S, Dupon, M, Neau, D, Pellegrin, JL, Malvy, D, Tchamgoué, S, Dabis, F, Morlat, P

    Published in HIV medicine (01-05-2010)
    “…Objectives The aims of the present study were to estimate the prevalence of renal impairment (RI) among HIV‐infected adult patients and to investigate the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Hepatitis C virus (HCV) protease variability and anti‐HCV protease inhibitor resistance in HIV/HCV‐coinfected patients by Trimoulet, P, Belzunce, C, Faure, M, Wittkop, L, Reigadas, S, Dupon, M, Ragnaud, J‐M, Fleury, H, Neau, D

    Published in HIV medicine (01-09-2011)
    “…Objectives Data on the natural selection of isolates harbouring mutations within the NS3 protease, conferring resistance to hepatitis C virus (HCV) protease…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Prolonged shedding of influenza A(H1N1)v virus: two case reports from France 2009 by Fleury, H, Burrel, S, Balick Weber, C, Hadrien, R, Blanco, P, Cazanave, C, Dupon, M

    “…We observed a prolonged shedding of virus 14 and 28 days after symptom onset in two patients with pandemic H1N1 influenza, who did not have immunodepression…”
    Get full text
    Journal Article
  10. 10

    Trends and determinants of severe morbidity in HIV‐infected patients: the ANRS CO3 Aquitaine Cohort, 2000–2004 by Bonnet, F, Chêne, G, Thiébaut, R, Dupon, M, Lawson‐Ayayi, S, Pellegrin, JL, Dabis, F, Morlat, P

    Published in HIV medicine (01-11-2007)
    “…Objective The aim of the study was to characterize the causes, trends and determinants of severe morbidity in a large cohort of HIV‐infected patients between…”
    Get full text
    Journal Article
  11. 11

    Risk Factors for Lactic Acidosis in HIV-Infected Patients Treated with Nucleoside Reverse-Transcriptase Inhibitors: A Case-Control Study by Bonnet, F., Bonarek, M., Morlat, P., Mercié, P., Dupon, M., Gemain, M. C., Malvy, D., Bernard, N., Pellegrin, J. L., Beylot, J.

    Published in Clinical infectious diseases (15-05-2003)
    “…A case-control study was undertaken to determine risk factors for lactic acidosis in human immunodeficiancy virus-infected patients treated with nucleoside…”
    Get full text
    Journal Article
  12. 12

    Carotid intima–media thickness is slightly increased over time in HIV‐1‐infected patients by Mercié, P, Thiébaut, R, Aurillac‐Lavignolle, V, Pellegrin, JL, Yvorra‐Vives, MC, Cipriano, C, Neau, D, Morlat, P, Ragnaud, JM, Dupon, M, Bonnet, F, Lawson‐Ayayi, S, Malvy, D, Roudaut, R, Dabis, F

    Published in HIV medicine (01-11-2005)
    “…Objectives HIV‐infected patients are at risk of atherosclerosis and cardiovascular diseases. In a 12‐month follow‐up study, we aimed to investigate changes in…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Prognostic factors in adult community-acquired bacterial meningitis : a 4-year retrospective study by DAUCHY, F. A, GRUSON, D, CHENE, G, VIOT, J, BEBEAR, C, MAUGEIN, J, BEZIAN, M. C, DUTRONC, H, DUPON, M

    “…The aim of this 4-year, observational, single-center study was to identify prognostic factors and evaluate the need for intensive care in cases of bacterial…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy by Duval, Xavier, Journot, Valérie, Leport, Catherine, Chêne, Geneviève, Dupon, Michel, Cuzin, Lise, May, Thierry, Morlat, Philippe, Waldner, Anne, Salamon, Roger, Raffi, François

    Published in Clinical infectious diseases (15-07-2004)
    “…Risk factors associated with the occurrence of protease inhibitor (PI)—related severe and serious adverse drug reactions (SADRs) were analyzed in a prospective…”
    Get full text
    Journal Article
  18. 18

    Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999–2001 by Bonnet, F, Balestre, E, Thiébaut, R, Mercié, P, Dupon, M, Morlat, P, Dabis, F

    Published in HIV medicine (01-05-2004)
    “…Objectives To describe the effect and tolerance of lipid‐lowering drugs (LLD; fibrates and statins) in patients treated with highly active antiretroviral…”
    Get full text
    Journal Article
  19. 19

    HIV‐1 reverse transcriptase (RT) genotypic patterns and treatment characteristics associated with the K65R RT mutation by Boucher, S, Recordon‐Pinson, P, Ragnaud, JM, Dupon, M, Fleury, H, Masquelier, B

    Published in HIV medicine (01-07-2006)
    “…Background The K65R HIV‐1 reverse transcriptase (RT) mutation is a multidrug resistance mutation which may be correlated with specific antiretroviral…”
    Get full text
    Journal Article
  20. 20

    Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients by Dupon, M. (Hopital Pellegrin, Bordeaux, France.), Cazenave, J, Pellegrin, J.L, Ragnaud, J.M, Cheyrou, A, Fischer, I, Leng, B, Lacut, J.Y

    Published in Journal of Clinical Microbiology (01-09-1995)
    “…To investigate whether both tissue culture and PCR on a sequence from the repetitive rDNA could contribute to the diagnosis of toxoplasmosis, blood samples…”
    Get full text
    Journal Article